Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1069)
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
100
Price
$223.50
Total Value
$22.35K
Shares Held After
900
% of Holdings
11.1%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$222.30
Total Value
$44.46K
Shares Held After
800
% of Holdings
25.0%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$223.76
Total Value
$44.75K
Shares Held After
600
% of Holdings
33.3%
CRISPR Therapeutics AG (CRSP)
Patel Naimish — Chief Medical Officer
Shares
3,786
Price
$55.62
Total Value
$210.58K
Shares Held After
19,357
% of Holdings
16.4%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,129
Price
$2.57
Total Value
$5.47K
Shares Held After
9,970
% of Holdings
21.4%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,786
Price
$2.57
Total Value
$4.59K
Shares Held After
17,131
% of Holdings
10.4%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,829
Price
$2.57
Total Value
$4.70K
Shares Held After
9,840
% of Holdings
18.6%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,582
Price
$2.57
Total Value
$4.07K
Shares Held After
9,176
% of Holdings
17.2%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,292
Price
$2.57
Total Value
$5.89K
Shares Held After
10,758
% of Holdings
21.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$559.41
Total Value
$179.01K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
841
Price
$558.81
Total Value
$469.96K
Shares Held After
40,833
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
918
Price
$557.80
Total Value
$512.06K
Shares Held After
41,674
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
461
Price
$556.67
Total Value
$256.62K
Shares Held After
42,592
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,000
Price
$555.59
Total Value
$555.59K
Shares Held After
43,053
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
817
Price
$554.57
Total Value
$453.08K
Shares Held After
44,053
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
823
Price
$553.73
Total Value
$455.72K
Shares Held After
44,870
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$552.58
Total Value
$375.75K
Shares Held After
45,693
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
986
Price
$551.34
Total Value
$543.62K
Shares Held After
46,373
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,605
Price
$550.60
Total Value
$883.71K
Shares Held After
47,359
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
769
Price
$549.59
Total Value
$422.64K
Shares Held After
48,964
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$548.60
Total Value
$153.61K
Shares Held After
49,733
% of Holdings
0.6%
Monte Rosa Therapeutics, Inc. (GLUE)
Townson Sharon — Chief Scientific Officer
Shares
6,000
Price
$19.87
Total Value
$119.22K
Shares Held After
67,845
% of Holdings
8.1%
MediWound Ltd. (MDWD)
Rubinstein Samuel — Director
Shares
150
Price
$14.33
Total Value
$2.15K
Shares Held After
2,993
% of Holdings
5.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
32,556
Price
$0.45
Total Value
$14.65K
Shares Held After
622,579
% of Holdings
5.0%
Alkermes plc. (ALKS)
Parisi Samuel Joseph — VP, Finance (Interim PAO)
Shares
16,217
Price
$42.36
Total Value
$687.01K
Shares Held After
7,717
% of Holdings
67.8%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,192
Price
$236.97
Total Value
$282.47K
Shares Held After
52,626
% of Holdings
2.2%
Q32 Bio Inc. (QTTB)
ORBIMED ADVISORS LLC — Director
Shares
625,000
Price
$8.00
Total Value
$5.00M
Shares Held After
625,000
% of Holdings
100.0%
Q32 Bio Inc. (QTTB)
ORBIMED ADVISORS LLC — Director
Shares
1,250,000
Price
$8.00
Total Value
$10.00M
Shares Held After
3,502,987
% of Holdings
35.7%
Q32 Bio Inc. (QTTB)
Xu Diyong — Director
Shares
625,000
Price
$8.00
Total Value
$5.00M
Shares Held After
625,000
% of Holdings
100.0%
Q32 Bio Inc. (QTTB)
Xu Diyong — Director
Shares
1,250,000
Price
$8.00
Total Value
$10.00M
Shares Held After
3,502,987
% of Holdings
35.7%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Ghiath M. — Director
Shares
8,539,709
Price
$0.59
Total Value
$5.00M
Shares Held After
22,092,068
% of Holdings
38.7%
PRECIGEN, INC. (PGEN)
Sabzevari Helen — President and CEO
Shares
119,250
Price
$4.36
Total Value
$519.93K
Shares Held After
3,768,872
% of Holdings
3.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
419
Price
$13.95
Total Value
$5.85K
Shares Held After
194,655
% of Holdings
0.2%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
2,441
Price
$13.95
Total Value
$34.05K
Shares Held After
939,634
% of Holdings
0.3%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
250
Price
$2.30
Total Value
$575.00
Shares Held After
5,779
% of Holdings
4.3%
PRECIGEN, INC. (PGEN)
Lehr Donald P. — Chief Legal Officer
Shares
29,131
Price
$4.36
Total Value
$127.01K
Shares Held After
755,461
% of Holdings
3.7%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
42,703
Price
$4.36
Total Value
$186.19K
Shares Held After
497,751
% of Holdings
7.9%
PRECIGEN, INC. (PGEN)
Tennant Phil — Chief Commercial Officer
Shares
30,272
Price
$4.36
Total Value
$131.99K
Shares Held After
139,369
% of Holdings
17.8%
PRECIGEN, INC. (PGEN)
Thomasian Harry Jr. — Chief Financial Officer
Shares
41,884
Price
$4.36
Total Value
$182.61K
Shares Held After
554,535
% of Holdings
7.0%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
1,669
Price
$109.30
Total Value
$182.42K
Shares Held After
59,634
% of Holdings
2.7%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
900
Price
$108.14
Total Value
$97.33K
Shares Held After
61,303
% of Holdings
1.4%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
1,530
Price
$107.45
Total Value
$164.40K
Shares Held After
62,203
% of Holdings
2.4%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
1,401
Price
$106.32
Total Value
$148.95K
Shares Held After
63,733
% of Holdings
2.2%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
100
Price
$109.76
Total Value
$10.98K
Shares Held After
58,117
% of Holdings
0.2%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,500
Price
$109.30
Total Value
$163.95K
Shares Held After
58,217
% of Holdings
2.5%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,178
Price
$108.01
Total Value
$127.24K
Shares Held After
59,717
% of Holdings
1.9%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,422
Price
$107.33
Total Value
$152.62K
Shares Held After
60,895
% of Holdings
2.3%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,300
Price
$106.26
Total Value
$138.14K
Shares Held After
62,317
% of Holdings
2.0%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
679
Price
$16.00
Total Value
$10.86K
Shares Held After
47,122
% of Holdings
1.4%
Jazz Pharmaceuticals plc (JAZZ)
Pearce Samantha — EVP, Chief Commercial Officer
Shares
6,907
Price
$235.41
Total Value
$1.63M
Shares Held After
50,272
% of Holdings
12.1%
Showing 551–600 of 1069 transactions (page 12 of 22)